People: Thoratec Corp (THOR.OQ)

THOR.OQ on NASDAQ Stock Exchange Global Select Market

42.31USD
24 Apr 2015
Change (% chg)

$-0.46 (-1.08%)
Prev Close
$42.77
Open
$42.82
Day's High
$42.82
Day's Low
$42.25
Volume
166,538
Avg. Vol
174,503
52-wk High
$44.74
52-wk Low
$22.50

Search Stocks

LaViolette, Paul 

Mr. Paul A. LaViolette is an Independent Director of Thoratec Corporation. Since January 2011. Mr. LaViolette is Managing Partner & Chief Operating Officer of SV Life Sciences, a venture capital adviser and manager in the life sciences sector, where he was a general partner from January 2011 until December 2013 and a venture partner from December 2008 until December 2010. Mr. LaViolette was Chief Operating Officer of Boston Scientific Corporation, a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties, from 2004 until 2008 and joined Boston Scientific in January 1994. Prior to becoming its Chief Operating Officer, Mr. LaViolette held positions with Boston Scientific as Senior Vice President and Group President, Cardiovascular for Boston Scientific's Scimed, EPT and Target businesses, President of Scimed, Senior Vice President and Group President-Nonvascular Businesses, and President, Boston Scientific International, and Vice President-International. Prior to joining Boston Scientific, he was employed by C.R. Bard, Inc. in various capacities, including President, U.S.C.I. Division, President, U.S.C.I. Angioplasty Division, Vice President and General Manager, U.S.C.I. Angioplasty Division, and Vice President U.S.C.I. Division. Mr. LaViolette serves as a member of the boards of directors of Baxano Surgical, Inc., TransEnterix, Inc. and several private medical technology companies, and formerly served as a member of the board of directors of Conceptus, Inc.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Neil Dimick

--

Taylor Harris

1,345,060

Niamh Pellegrini

1,695,020

David Lehman

1,242,100

Vasant Padmanabhan

1,740,500

D. Keith Grossman

10,530,200
As Of  30 Dec 2014
Search Stocks